Group Leader
                                            Fernando Azpiroz Vidaur                                        
                                            Principal Investigator (PI)
                                            Carmen Alonso Cotoner, Natalia Borruel Sainz, Francesc Casellas Jorda, Danila Guagnozzi, Beatriz Lobo Alvarez, Carolina Malagelada Prats, Francesc Xavier Molero Richard, Francisco Javier Santos Vicente, Jorge Serra Pueyo, María Vicario Pérez                                        
                                            Researchers
                                            Luís Alcalá González, Claudia Barber Casellas, Ana María González Castro, Blanca Grases Pintó, Claudia Herrera De Guise, Ronald Llerena Castro, Virginia Robles Alonso, Teodora Pribic, Francisca Yañez Araya, Encarna Varela Castro                                        
                                            PhD Students
                                            Lara Aguilera Castro, Elena Cespedes Martinez, Luís Mayorga Ayala, Xavier Serra Ruiz, Stephanie Tasayco, Xavier Serra Ruíz, Ariadna Aguilar Cayuelas, Laura Campderros Traver, Mercé Albert Bayo                                        
                                        Lab Technicians
                                            Laura Hui Perez Guerrero, Elba Expósito Fernández, Marta Far Serrano                                        
                                        Nursing and Technical Staff
                                            Consuelo Cammarota, Laia Comas Fernández, Adoración Nieto Ruíz, Josefina Heredia Montiel, Gloria Santaliestra Vivaracho                                        
41
PUBLICATIONS
34.1%
%Q1
252
IMPACT FACTOR
6.14
AVERAGE IMPACT FACTOR
SELECTED ARTICLES
                                                        Kartal E, Schmidt TSB, Molina-Montes E, Rodriguez-Perales S, Wirbel J, Maistrenko OM, Akanni WA, Alashkar Alhamwe B, Alves RJ, Carrato A, Erasmus HP, Estudillo L, Finkelmeier F, Fullam A, Glazek AM, Gomez-Rubio P, Hercog R, Jung F, Kandels S, Kersting S, Langheinrich M, Marquez M, Molero X, Orakov A, Van Rossum T, Torres-Ruiz R, Telzerow A, Zych K, Benes V, Zeller G, Trebicka J, Real FX, Malats N, Bork P, Malats N, Real FX, deMaturana EL, Gomez-Rubio P, Molina-Montes E, Alonso L, Marquez M, Milne R, Alfaro A, Lobato T, Estudillo L, Lawlor R, Scarpa A, Beghelli S, Sharp L, Hidalgo M, Rodriguez J, Carrato A, Caminoa A, Guillen-Ponce C, Rodriguez-Garrote M, Longo-Munoz F, Ferreiro R, Pachon V, Mar Iglesias LI, Alvarez-Urturi C, Bessa X, Bory F, Marquez L, Poves I, Burdio F, Grande L, Gimeno J, Molero X, Guarner L, Balcells J, Salcedo M, Michalski C, Esposito I, Kleeff J, Kong B, Lohr M, Huang J, Verbeke C, Ye W, Yu J, Perea J, Pelaez P, Farre A, Mora J, Martin M, Artigas V, Guarner C, JSancho F, yCajal TR, Greenhalf W, O'Rorke M, Murray L, Cantwell M, MBarbera V, Tardon A, Barneo L, Munoz ED, Lozano A, Luaces M, Munoz-Bellvis L, Sayagues Manzano JM, Gutierrrez Troncoso , deMatos A, Gress T, Buchholz M, Neesse A, Crnogorac-Jurcevic T, Kocher HM, Bhattacharya S, Tabraham A, Ennis D, Dowe T, Radon T, Silverman DT, Easton D, Hans-Peter JT, FabianFinkelmeier E, WenyiGuOlaf RS, Erhard T, Stefan U, Kersting S, Langheinrich M, Grutzmann R, FWeber G, Pilarsky C
                                                        A faecal microbiota signature with high specificity for pancreatic cancer
                                                        Gut. 2022 Jul;71(7):1359-1372. 
                                                        DOI: doi: 10.1136/gutjnl-2021-324755. 
                                                        IF: 31.80
                                                    
                                                        Marasco G, Cremon C, Barbaro MR, Cacciari G, Falangone F, Kagramanova A, Bordin D, Drug V, Miftode E, Fusaroli P, Mohamed SY, Ricci C, Bellini M, Rahman MM, Melcarne L, Santos J, Lobo B, Bor S, Yapali S, Akyol D, Sapmaz FP, Urun YY, Eskazan T, Celebi A, Kacmaz H, Ebik B, Binicier HC, Bugdayci MS, Yagci MB, Pullukcu H, Kaya BY, Tureyen A, Hatemi I, Koc ES, Sirin G, Caliskan AR, Bengi G, Alis EE, Lukic S, Trajkovska M, Hod K, Dumitrascu D, Pietrangelo A, Corradini E, Simren M, Sjolund J, Tornkvist N, Ghoshal UC, Kolokolnikova O, Colecchia A, Serra J, Maconi G, De Giorgio R, Danese S, Portincasa P, Di Sabatino A, Maggio M, Philippou E, Lee YY, Salvi D, Venturi A, Borghi C, Zoli M, Gionchetti P, Viale P, Stanghellini V, Barbara G, Piacentini A, Shengelia M, Vechorko V, Cardamone C, Rosei CA, Pancetti A, Rettura F, Pedrosa M, Nieto A, Barber C, Henao A, Campoli C, Mijac D, Korac M, Karic U, Markovic A, Najdeski A, Nikolova D, Dimzova M, Lior O, Shinhar N, Perelmutter O, Ringel Y, Sabo CM, Chis A, Bonucchi G, Ismaele Caio GP, Ghirardi C, Marziani B, Rizzello B, Aguilar A, Di Paolo DM, Bonfrate L, Marconi G, Stefano MD, Tagliaferri S, Naves JE, Galli A, Dragoni G, Nedelcu L, Stevanovic M, Nikolovska AV, Capogreco A, Aghemo A, Mauloni PA, Vecchio SD, Rotondo L, Capuani F, Montanari D, Palombo F, Paone C, Mastel G, Fontana C, Bellacosa L, Cogliandro RF
                                                        Post COVID-19 irritable bowel syndrome
                                                        Gut. 2022 Dec 9:gutjnl-2022-328483
                                                        DOI: doi: 10.1136/gutjnl-2022-328483
                                                        IF: 31.80
                                                    
                                                        Marasco G, Cremon C, Barbaro MR, Salvi D, Cacciari G, Kagramanova A, Bordin D, Drug V, Miftode E, Fusaroli P, Mohamed SY, Ricci C, Bellini M, Rahman MM, Melcarne L, Santos J, Lobo B, Bor S, Yapali S, Akyol D, Sapmaz FP, Urun YY, Eskazan T, Celebi A, Kacmaz H, Ebik B, Binicier HC, Bugdayci MS, Yagci MB, Pullukcu H, Kaya BY, Tureyen A, Hatemi I, Koc ES, Sirin G, Caliskan AR, Bengi G, Alis EE, Lukic S, Trajkovska M, Hod K, Dumitrascu D, Pietrangelo A, Corradini E, Simren M, Sjolund J, Tornkvist N, Ghoshal UC, Kolokolnikova O, Colecchia A, Serra J, Maconi G, De Giorgio R, Danese S, Portincasa P, Di Stefano M, Maggio M, Philippou E, Lee YY, Venturi A, Borghi C, Zoli M, Gionchetti P, Viale P, Stanghellini V, Barbara G
                                                        Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study
                                                        Am J Gastroenterol. 2022 Jan 1;117(1):147-157
                                                        DOI: doi: 10.14309/ajg.0000000000001541
                                                        IF: 12.05
                                                    
                                                        Lesnovska KP, Munch A, Bonderup O, Magro F, Kupcinskas J, Zabana Y, Tontini GE, Munck LK, Guagnozzi D, Latella G, Fernandez-Banares F, Miehlke S, Madisch A, Wildt S, Hjortswang H
                                                        The Process of Developing a Disease Activity Index in Microscopic Colitis
                                                        J Crohns Colitis. 2022 Mar 14;16(3):452-459 
                                                        DOI: doi: 10.1093/ecco-jcc/jjab170
                                                        IF: 10.02
                                                    
                                                        Salvo-Romero E, Rodino-Janeiro BK, Albert-Bayo M, Lobo B, Santos J, Farre R, Martinez C, Vicario M
                                                        Eosinophils in the Gastrointestinal Tract: Key Contributors to Neuro-Immune Crosstalk and Potential Implications in Disorders of Brain-Gut Interaction
                                                        Cells. 2022 May 14;11(10). pii: cells11101644
                                                        DOI: doi: 10.3390/cells11101644
                                                        IF: 7.67
                                                    
                                            NEUROGASTRO -Neurofisiología y neurofisiopatología digestiva
                                            Principal Investigator:  Fernando Azpiroz Vidaur
                                                                                            Agency: Ministerio de Ciencia e Innovación-MICINN
                                                                                                                                        Funding: 108,900€
                                                                                                                                        Period: 01/09/2022 - 01/09/2026
                                                                                    
                                            Contribución diferencial del epitelio intestinal a la fisiopatología de la diarrea crónica en el síndrome del intestino irritable y la colitis microscópica. Perfil clínico-biológico para el diagnóstico diferencial.
                                            Principal Investigator: IP: Maria Vicario Perez Collaborators: Beatriz Lobo Alvarez, Merce Albert Bayo, Inés de Torres Ramirez, Ana Maria Gonzalez Castro, Marc Pigrau Pastor, Xavier Serra Ruiz 
                                                                                            Agency: Instituto de Salud Carlos III. Referencia: PI19/01643
                                                                                                                                        Funding: 183,920€
                                                                                                                                        Period: 01/01/2020 - 30/06/2024
                                                                                    
                                            Identificación de un panel integrado de biomarcadores no invasivos predictivos del diagnóstico de colitis microscópica
                                            Principal Investigator: Danila Guagnozzi 
                                                                                            Agency: Instituto de Salud Carlos III. PI17/01443	
                                                                                                                                        Funding: 159,720€
                                                                                                                                        Period: 01/01/2018 - 30/06/2022
                                                                                    
                                            CFTR down regulation enhances pancreatic carcinogenesis and promotes cancer invasion and metastasis
                                            Principal Investigator: Francesc Xavier Molero Richard
                                                                                            Agency: Cistic Fibrosis Foundation 
                                                                                                                                        Funding:  307,328€ 
                                                                                                                                        Period: 01/05/2022 - 30/04/2023
                                                                                    
                                            Development, dIagnostic and prevention of gender-related Somatic and mental COmorbitiEs in IRritable bowel syndrome In Europe (DISCOvERIE)
                                            Principal Investigator: Fco Javier Santos Vicente
                                                                                            Agency: EUROPEAN COMMISSION. H2020-SC1-BHC-01-2019
                                                                                                                                        Funding:  1,147,462.49 € 
                                                                                                                                        Period: 01/01/2020 - 31/12/2024
                                                                                    
                                            Owner of the intellectual property rights of the questionnaire “QUECOMIICAT”
                                                                                            Priority Number:  B-390-18 2018
                                                                                                                                        Priority Date: 2018
                                                                                                                                        Applicants: VHIR, Given